- Citations, last 5 years
- 94
- Works, last 5 years
- 11
- h-index
- 19
- Scientists listed
- 2
- Grants since 2016
- 8
Grants received
2019–2020 · research · R43
A microfluidic platform for the high-throughput isolation circulating fetal trophoblasts for non-invasive prenatal testing
Rolf Muller · BioFluidica (United States) · funded by National Institutes of Health
2019–2021 · research · R44
Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia
Rolf Muller · BioFluidica (United States) · funded by National Institutes of Health
2019–2022 · research · R44
Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia
Rolf Muller · BioFluidica (United States) · funded by National Institutes of Health
2018–2019 · research · R44
Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia
Rolf Muller · BioFluidica (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Parallel and high throughput isolation of cancer cell derived extracellular vesicles
Rolf Muller · BioFluidica (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Parallel and high throughput isolation of cfDNA to target detection of rare, highly conserved nucleotide polymorphisms
Rolf Muller · BioFluidica (United States) · funded by National Institutes of Health
2017–2019 · research · R44
Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood
Rolf Muller · BioFluidica (United States) · funded by National Institutes of Health
2017–2020 · research · R44
Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood
Rolf Muller · BioFluidica (United States) · funded by National Institutes of Health
